Foundation Fighting Blindness Retinal Degeneration Fund disposes of Opus Genetics common shares worth $2,756,020.80

Bitget2026/10/02 23:47

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Foundation Fighting Blindness Retinal Degeneration Fund sold 556,000 Opus Genetics common shares on Sept. 30, 2026.
Sale priced at USD 4.9568 per share on a weighted-average basis.
Stake fell to 3,236,171 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opus Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002042266-26-000002), on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Foundation Fighting Blindness Retinal Degeneration Fund disposes of Opus Genetics common shares worth $2,756,020.80

You may also like

Crypto prices